Cyteir Therapeutics(CYT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYT Cyteir Therapeutics

退市 04-16 11:28:15 EDT

3.02

+0.00

0.00%

最高3.02	最低3.02	成交量0.00
今开3.02	昨收3.02	日振幅0.00%
总市值1.09亿	流通市值3,271万	总股本3,599万
成交额0.00	换手率0.00%	流通股本1,083万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYT","market":"US","secType":"STK","nameCN":"Cyteir Therapeutics","latestPrice":3.02,"timestamp":1744817295355,"preClose":3.02,"halted":4,"volume":0,"delay":0,"floatShares":10832635,"shares":35990735,"eps":-0.934432,"marketStatus":"退市","change":0,"latestTime":"04-16 11:28:15 EDT","open":3.02,"high":3.02,"low":3.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.934432,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1744833600000},"marketStatusCode":2,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":3.02,"volumeRatio":0},"requestUrl":"/m/hq/s/CYT","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.cyteir.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0828},{"period":"1month","weight":-0.0448},{"period":"3month","weight":-0.0931},{"period":"6month","weight":-0.0768},{"period":"1year","weight":0.0657},{"period":"ytd","weight":-0.0827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyteir Therapeutics, Inc.成立于2012年6月4日，是一家特拉华州公司。他们是一家临床阶段的生物技术公司，专注于开发和商业化下一代精确肿瘤药物，通过一种被称为合成致命的治疗策略来抑制DNA损伤修复并导致癌细胞死亡。合成致死率是一种经过临床验证的药物开发方法，当两种条件中的任何一种缺乏时就会出现，这两种条件单独在细胞中是可以耐受的，但在一起是致命的。他们的主要项目CYT-0851，以及下一代候选药物CYT-1853，利用了一种新的功能获得合成致死关系，即DNA损伤基因家族胞苷脱氨酶(CDs)的过度表达与同源重组(HR)的功能抑制之间的关系，同源重组是一种对某些癌症存活至关重要的DNA修复途径。","yearOnYearQuotes":[{"month":1,"riseRate":0.590909,"avgChangeRate":0.021607},{"month":2,"riseRate":0.590909,"avgChangeRate":0.028832},{"month":3,"riseRate":0.545455,"avgChangeRate":0.019072},{"month":4,"riseRate":0.590909,"avgChangeRate":0.045183},{"month":5,"riseRate":0.545455,"avgChangeRate":0.008829},{"month":6,"riseRate":0.521739,"avgChangeRate":0.002607},{"month":7,"riseRate":0.636364,"avgChangeRate":0.064157},{"month":8,"riseRate":0.5,"avgChangeRate":0.022554},{"month":9,"riseRate":0.5,"avgChangeRate":0.008662},{"month":10,"riseRate":0.545455,"avgChangeRate":0.018977},{"month":11,"riseRate":0.545455,"avgChangeRate":0.003679},{"month":12,"riseRate":0.727273,"avgChangeRate":0.028065}],"exchange":"NASDAQ","name":"Cyteir Therapeutics","nameEN":"Cyteir Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyteir Therapeutics(CYT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyteir Therapeutics(CYT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyteir Therapeutics,CYT,Cyteir Therapeutics股票,Cyteir Therapeutics股票老虎,Cyteir Therapeutics股票老虎国际,Cyteir Therapeutics行情,Cyteir Therapeutics股票行情,Cyteir Therapeutics股价,Cyteir Therapeutics股市,Cyteir Therapeutics股票价格,Cyteir Therapeutics股票交易,Cyteir Therapeutics股票购买,Cyteir Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyteir Therapeutics(CYT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyteir Therapeutics(CYT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}